Keith T. Flaherty
Cancer Research Center(US)
Publications by Year
Research Areas
Melanoma and MAPK Pathways, Cancer Immunotherapy and Biomarkers, Cutaneous Melanoma Detection and Management, CAR-T cell therapy research, Cancer Genomics and Diagnostics
Most-Cited Works
- → Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation(2011)7,653 cited
- → Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq(2016)5,063 cited
- → Final Version of 2009 AJCC Melanoma Staging and Classification(2009)4,551 cited
- → Inhibition of Mutated, Activated BRAF in Metastatic Melanoma(2010)3,526 cited
- → Genomic Classification of Cutaneous Melanoma(2015)3,198 cited
- → Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations(2012)2,783 cited
- → Improved Overall Survival in Melanoma with Combined Dabrafenib and Trametinib(2014)2,622 cited
- → Melanoma staging: Evidence‐based changes in the American Joint Committee on Cancer eighth edition cancer staging manual(2017)2,248 cited
- → Survival in BRAF V600–Mutant Advanced Melanoma Treated with Vemurafenib(2012)2,141 cited
- → Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma(2012)2,130 cited